158 related articles for article (PubMed ID: 17420962)
1. Differential expressions of cyclin D1 associated with better prognosis of cancers of ampulla of Vater.
Chang MC; Chang YT; Sun CT; Chiu YF; Lin JT; Tien YW
World J Surg; 2007 May; 31(5):1135-41. PubMed ID: 17420962
[TBL] [Abstract][Full Text] [Related]
2. Expression of p16 protein and cyclin D1 in periampullary carcinomas.
Tuncer E; Türk NS; Arici S; Düzcan SE; Demirkan NC
Turk Patoloji Derg; 2011 Jan; 27(1):17-22. PubMed ID: 21469422
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
4. Histological and Molecular Subclassification of Pancreatic and Nonpancreatic Periampullary Cancers: Implications for (Neo) Adjuvant Systemic Treatment.
Erdmann JI; Eskens FA; Vollmer CM; Kok NF; Groot Koerkamp B; Biermann K; van Eijck CH
Ann Surg Oncol; 2015 Jul; 22(7):2401-7. PubMed ID: 25503345
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information.
Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Bendigtsen Schirmer C; Renolen A; Borgen E; Naume B; Wiedswang G
BMC Cancer; 2020 Nov; 20(1):1107. PubMed ID: 33198661
[TBL] [Abstract][Full Text] [Related]
6. Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis.
Beghelli S; Orlandini S; Moore PS; Talamini G; Capelli P; Zamboni G; Falconi M; Scarpa A
Virchows Arch; 2002 Jul; 441(1):19-24. PubMed ID: 12111196
[TBL] [Abstract][Full Text] [Related]
7. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of E-cadherin, β-catenin, and S100A4 in intestinal type and nonintestinal type ampulla of Vater cancers.
Sung R; Kang L; Han JH; Choi JW; Lee SH; Lee TH; Park SH; Kim HJ; Lee ES; Kim YS; Choi YW; Park SM
Gut Liver; 2014 Jan; 8(1):94-101. PubMed ID: 24516707
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical study of a primary signet-ring cell carcinoma of the ampulla of vater: a case report.
Terada T
J Gastrointest Cancer; 2013 Dec; 44(4):463-5. PubMed ID: 23250705
[No Abstract] [Full Text] [Related]
10. Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker.
Chong Y; Thakur N; Paik KY; Lee EJ; Kang CS
BMC Cancer; 2020 Mar; 20(1):216. PubMed ID: 32171280
[TBL] [Abstract][Full Text] [Related]
11. The correlation of cortactin and fascin-1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma.
Tsai WC; Lin CK; Lee HS; Gao HW; Nieh S; Chan DC; Jin JS
APMIS; 2013 Mar; 121(3):171-81. PubMed ID: 23030700
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
Roder JD; Siewert JR
Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.
Yun SP; Seo HI
BMC Gastroenterol; 2015 Nov; 15():165. PubMed ID: 26603157
[TBL] [Abstract][Full Text] [Related]
15. Surgical outcomes and prognostic factors for ampulla of Vater cancer.
Choi SB; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
Scand J Surg; 2011; 100(2):92-8. PubMed ID: 21737384
[TBL] [Abstract][Full Text] [Related]
16. [Expression of hedgehog proteins in periampullary cancer].
Lee SY; Lee KT; Jang KT; Choi SH; Heo JS; Kim DH; Lee JK; Paik SW; Rhee JC
Korean J Gastroenterol; 2005 Oct; 46(4):291-6. PubMed ID: 16247273
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic and periampullary cancers: treatment and outcome.
Spalding DR
Br J Hosp Med (Lond); 2006 Jan; 67(1):14-20. PubMed ID: 16447398
[No Abstract] [Full Text] [Related]
18. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
[TBL] [Abstract][Full Text] [Related]
19. Advances in Molecular Pathology and Treatment of Periampullary Cancers.
Chandrasegaram MD; Chen JW; Price TJ; Zalcberg J; Sjoquist K; Merrett ND
Pancreas; 2016 Jan; 45(1):32-9. PubMed ID: 26348463
[TBL] [Abstract][Full Text] [Related]
20. Transduodenal local resection for low-risk group ampulla of vater carcinoma.
Park JS; Yoon DS; Park YN; Lee WJ; Chi HS; Kim BR
J Laparoendosc Adv Surg Tech A; 2007 Dec; 17(6):737-42. PubMed ID: 18158802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]